Evidence map›Paper›PMID 33189783›Full record

ReviewBiochimica et biophysica acta. Molecular cell research2021

Unraveling the multifaceted nature of the nuclear function of mTOR.

Alek S Torres, Marina K Holz

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta. Molecular cell research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Neuroprotective effects ofFrontiers in molecular biosciences · 2026
    Article
  2. Spatial dynamics of mTOR pathway activity during bovine embryo development.Frontiers in cell and developmental biology · 2026
    Article
  3. The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis.American journal of respiratory cell and molecular biology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Regulation of nuclear mTORC1.Molecular & cellular oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alek S TorresDepartment of Biochemistry and Molecular Biology, Graduate School of Basic Medical Sciences, New York Medical College, Valhalla, NY 10595, United States of America.
Marina K HolzDepartment of Cell Biology and Anatomy, Graduate School of Basic Medical Sciences, New York Medical College, Valhalla, NY 10595, United States of America. Electronic address: mholz@nymc.edu.

Funding

Estrogenic signaling upstream and downstream of mTORR35GM128675 · NIGMS · NEW YORK MEDICAL COLLEGE · PI HOLZ, MARINA K · 2018 to 2022
$2.4M
NIGMS NIH HHS R35 GM128675
6 · The paper itself

Abstract

Positioned at the axis between the cell and its environment, mTOR directs a wide range of cellular activity in response to nutrients, growth factors, and stress. Our understanding of the role of mTOR is evolving beyond the spatial confines of the cytosol, and its role in the nucleus becoming ever more apparent. In this review, we will address various studies that explore the role of nuclear mTOR (nmTOR) in specific cellular programs and how these pathways influence one another. To understand the emerging roles of nuclear mTOR, we discuss data and propose plausible mechanisms to offer novel ideas, hypotheses, and future research directions.

Indexed as

Cell NucleusHumansTOR Serine-Threonine KinasesMTOR protein, humanTOR Serine-Threonine KinasesKinasemTORNuclear receptorNucleusRapamycinSignaling

Identifiers

PMID33189783
PMCPMC7725927

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.